Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Inbar

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Cancer|December 1, 1990
Interleukin-2-induced lung permeability is mediated by leukotriene B4J M Klausner, G Goldman, Y Skornick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancerO Merimsky, A Staroselsky, M Inbar, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1978
Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanismsM Petitou, F Tuy, C Rosenfeld, et al.
Cancer|August 1, 1991
Are malignant melanoma patients at higher risk for a second cancer?M Gutman, A Cnaan, M Inbar, et al.
Anti-Cancer Drugs|May 2, 2000
Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II studyO Merimsky, N Wigler, Y Greif, et al.
Journal of Surgical Oncology|March 1, 1987
Nail-bed melanomaJ M Klausner, M Inbar, M Gutman, et al.
Clinical Oncology|March 1, 1983
Breast carcinoma originating in cystosarcoma phyllodesJ M Klausner, S Lelcuk, B Ilia, et al.
Oncology Reports|May 19, 2011
Amputation of the lower limb as palliative treatment for debilitating musculoskeletal cancerO Merimsky, Y Kollender, J Bickels, et al.
Molecular Biotherapy|September 1, 1990
Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinomaO Merimsky, M Inbar, E Merimsky, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Cancer|December 1, 1990
Interleukin-2-induced lung permeability is mediated by leukotriene B4J M Klausner, G Goldman, Y Skornick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancerO Merimsky, A Staroselsky, M Inbar, et al.
Melanoma Research|April 1, 1996
Intra-arterial chemotherapy with concomitant hemofiltration (chemofiltration) for treatment of loco-regional or pelvic metastases from malignant melanomaM Gutman, S Abu-Abid, M Inbar, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1978
Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanismsM Petitou, F Tuy, C Rosenfeld, et al.
Cancer|August 1, 1991
Are malignant melanoma patients at higher risk for a second cancer?M Gutman, A Cnaan, M Inbar, et al.
Anti-Cancer Drugs|May 2, 2000
Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II studyO Merimsky, N Wigler, Y Greif, et al.
Journal of Surgical Oncology|March 1, 1987
Nail-bed melanomaJ M Klausner, M Inbar, M Gutman, et al.
Clinical Oncology|March 1, 1983
Breast carcinoma originating in cystosarcoma phyllodesJ M Klausner, S Lelcuk, B Ilia, et al.
Oncology Reports|May 19, 2011
Amputation of the lower limb as palliative treatment for debilitating musculoskeletal cancerO Merimsky, Y Kollender, J Bickels, et al.
Molecular Biotherapy|September 1, 1990
Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinomaO Merimsky, M Inbar, E Merimsky, et al.
Pageof 18